YAP1 can also activate Foxm1, which is a crucial regulator of insulin resistance and lipid metabolism and contributes to the progression of MASLD (Jeong et al., 2018). This evidence concerns the gene YAP1 and metabolic dysfunction-associated steatotic liver disease.